In this video, Motley Fool health-care analyst David Williamson takes a closer look at Sarepta's (SRPT 5.25%) big move on Friday. Wall Street is starting to wake up to this small biotech story and several key catalysts in the coming months could attract even more attention.
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.